Abstract
BackgroundPsoriasis is a highly heterogeneous autoinflammatory disease[1]. Molecular and cellular characteristics of the patient skin are major determinants of clinical outcome for a given treatment[2].Current disease heterogeneity has not been...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
